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 13 
GnRH neurons are fundamental for reproduction in all vertebrates ultimately 14 
integrating all reproductive inputs. The inaccessibility of human GnRH-15 
neurons has been a major impediment to studying the central control of 16 
reproduction and its disorders. Here, we report the efficient generation of 17 
kisspeptin responsive GnRH-secreting neurons by directed differentiation of 18 
human Pluripotent Stem Cells. The protocol involves the generation of 19 
intermediate Neural Progenitor Cells (NPCs) through long-term Bone 20 
morphogenetic protein 4 inhibition followed by terminal specification of these 21 
NPCs in media containing FGF8 and a NOTCH inhibitor. The resulting GnRH 22 
expressing and secreting neurons display a neuroendocrine gene expression 23 
pattern and present spontaneous calcium transients that can be stimulated by 24 
kisspeptin. These in vitro generated GnRH expressing cells provide a new 25 
resource for studying the molecular mechanisms underlying the development 26 
and function of GnRH neurons. 27 
28 
 2 
Introduction 29 
 30 
GnRH neurons are fundamental for reproduction in all vertebrates. They not 31 
only determine the timing of puberty but ultimately integrate all reproductive 32 
inputs (Romanelli et al., 2004; Stevenson et al., 2013). In humans, the GnRH-33 
neuronal network is composed of a few hundred neurons distributed as 34 
clusters located from the preoptic area to the anterior hypothalamic regions 35 
making in vivo or ex vivo experimental studies of GnRH neurons extremely 36 
difficult (Maggi et al., 2000; Wang et al., 2015). The molecular ontogeny of 37 
GnRH neurons remains elusive. It is generally accepted that most 38 
hypothalamic GnRH neurons originate in the olfactory placode (OP) but 39 
compelling evidence suggests that a significant proportion of GnRH neurons 40 
may descend from neural crest progenitors (either directly or via their early 41 
migration to the OP) (Forni et al., 2011; Forni and Wray, 2012). Bone 42 
morphogenetic protein-4 (BMP4) plays an essential role in the formation of 43 
the olfactory placode (Leung et al., 2013) and GnRH neurons arise from the 44 
olfactory placode in a niche defined by gradients of BMP4/Noggin and FGF8 45 
(Forni et al., 2013; Sabado et al., 2012). After arising in the olfactory placode, 46 
GnRH neurons migrate to their final location in the anterior hypothalamus 47 
during embryonal development. Failure of these neurons to reach their 48 
appropriate place in the hypothalamus or to form functional networks has 49 
been associated with many reproductive phenotypes including delayed or 50 
absent puberty (Boehm et al., 2015; Howard et al., 2016). Some pubertal 51 
disorders such as Kallmann syndrome (where puberty is never or only 52 
partially completed) are often associated with anosmia (the inability to 53 
perceive odours) pointing to the common origin of olfactory and GnRH 54 
neurons (Forni and Wray, 2015; Herbison, 2007; Tucker et al., 2010). 55 
GnRH neurons secrete GnRH peptide in a pulsatile fashion. The frequency 56 
and amplitude of these secretory pulses changes during reproductive 57 
development and reproductive cycles, for example during puberty or the 58 
menstrual cycle (Apter, 1997; Barbieri, 2014; Ojeda et al., 2010). The pulsatile 59 
release of GnRH is controlled by the periodicity and amplitude of action 60 
potentials and calcium transients. These are regulated by several 61 
neuropeptides including kisspeptin, neurokinin B, and GABA (Constantin et 62 
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al., 2009; Ronnekleiv and Kelly, 2013; Verma et al., 2014). Of particular 63 
interest, kisspeptin and its receptor -the GPCR Kiss1R- have been implicated 64 
in several reproductive disorders (Clarke et al., 2015). Activation of Kiss1R 65 
causes an increase in the frequency and amplitude of calcium transients in 66 
GnRH neurons partly by inhibiting A-type and inwardly rectifying K+ currents 67 
and activating non-selective cation (TRPC) currents (Lee et al., 2010; 68 
Ronnekleiv and Kelly, 2013). 69 
Cell line models of GnRH neurons exist and they have proven useful for 70 
unpicking mechanisms of GnRH regulation. These cell lines however have 71 
been generated from tumours and represent static models of neurons at a 72 
fixed developmental stage (Constantin et al., 2009; Radovick et al., 1991; 73 
Romanelli et al., 2004). 74 
Pluripotent Stem Cells (PSCs)-derived neurons have been used successfully 75 
to model several human disease conditions in the lab (Hibaoui et al., 2014; 76 
Liu and Deng, 2016; Mattis and Svendsen, 2015). An in vitro model of PSCs-77 
derived GnRH neurons could help not only in understanding the normal 78 
development of this unique subset of neurons but it could be used to 79 
investigate aberrant development of conditions such as Kallmann syndrome 80 
and as a platform for drug discovery and functional genomics. 81 
Here we describe a protocol that consistently and efficiently generates GnRH-82 
expressing and secreting cells (GnRH-ECs) from human PSCs. Analysis of 83 
their gene expression profile and response to kisspeptin suggest that these in 84 
vitro generated neurons functionally resemble GnRH neurons. 85 
 86 
87 
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Results 88 
 89 
Generation of Neural Progenitor Cells (NPCs) 90 
To generate human GnRH-expressing cells we started by producing NPCs 91 
adapting a protocol previously published by Gerrard et al. (Gerrard et al., 92 
2005). This protocol involves culturing ESCs under neurogenic conditions for 93 
several passages using Basal Neuro-Epithelial (BNE) medium supplemented 94 
with the BMP inhibitor noggin (Fig 1A). As expected, during the development 95 
of NPCs, pluripotency markers were downregulated whereas neuronal 96 
markers were upregulated (Fig 1B). NPCs readily differentiated into neurons 97 
after withdrawal of growth factors (Suppl Fig 1). The differentiation process 98 
produced NPCs with similar efficiencies from human Embryonic Stem Cells 99 
(ESCs) and induced Pluripotent Stem Cells (iPSCs) derived from individuals 100 
with Kallmann Syndrome and their healthy family members (Fig 1 C and D). 101 
After passage 4 (P4) noggin was withdrawn and the cells were expanded in 102 
BNE medium supplemented with bFGF and EGF for up to 4 passages. It has 103 
been reported that the development of GnRH neurons in the olfactory 104 
epithelium depends on a neurogenic environment provided by an interplay 105 
between BMP4 and FGF8 signalling (Forni et al., 2013; Leung et al., 2013; 106 
Sabado et al., 2012). FGF8 is essential for GnRH neurons development in 107 
vivo and it has been used previously to differentiate chicken olfactory placode 108 
progenitors into GnRH neurons (Sabado et al., 2012). 109 
 110 
GnRH neuronal specification 111 
For the second stage of our differentiation protocol we removed bFGF and 112 
EGF from our medium and incubated the NPCs in medium supplemented with 113 
10 ng/ml FGF8 for 21 days. This led to significantly elevated levels of GnRH 114 
mRNA and protein (Fig 2 B-D). GnRH was also detected by ELISA in the cell 115 
media (Fig 2 E). In addition, NPCs in FGF8 supplemented medium adopted a 116 
mature neuronal morphology forming neurospheres and generating 117 
projections (Fig 2A). After plating the NPCs in FGF8 for differentiation, the 118 
cells still went through several rounds of division. We found that a correct 119 
initial cell density was essential for achieving an efficient 120 
differentiation/specification. We determined an optimal plating density of 121 
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between 5000 to 7500 cells/cm2. The notch inhibitor DAPT has been used 122 
previously to induce mitotic arrest and to promote neuronal differentiation from 123 
ESCs (Borghese et al., 2010). We therefore decided to treat the cells during 124 
the first week of differentiation with 5 M DAPT to induce mitotic arrest and 125 
aid differentiation. 126 
To investigate the proportions of GnRH-Expressing Cells (GnRH-ECs) after 127 
21 days of differentiation we stained the cells with an anti-GnRH antibody 128 
which has been consistently used to visualise GnRH neurons in both human 129 
and mouse hypothalami (Howard et al., 2016). The majority of TUJ1 positive 130 
cells expressed GnRH (Fig 3 A). Furthermore, GnRH staining was presented 131 
in a punctate pattern typical of neuropeptides which are packaged into 132 
vesicles. Our differentiation protocol also produced GnRH-expressing neurons 133 
from iPSCs derived from both Kallmann syndrome patients and their healthy 134 
family members (Fig 3 B). To quantify the proportion of GnRH positive 135 
neurons we analysed 21 days differentiated cells using flow cytometry (Fig 136 
3C). The proportion of GnRH positive cells derived from ESCs varied between 137 
experiments but it was always over 60% (Fig 3 Dc and Dd). Cultures of 138 
mouse GN11 cells -a model for immature, migratory GnRH neurons- 139 
contained similar proportions of positive cells (Fig 3 Db). The proportion of 140 
GnRH-positive cells varied between 40 and 50% in GnRH-ECs derived from 141 
iPSCs (Fig 3 De and Df). Human Embryonic Kidney-derived cells (HEK293) 142 
did not stain positively for GnRH (Fig 3 Da). 143 
 144 
Gene expression profiling of PSCs-derived GnRH expressing cells. 145 
After confirming that our protocol reliably produced neuronal cultures with high 146 
numbers of GnRH-positive neurons we looked for other genes known to be 147 
expressed in GnRH neurons (Fig 4). In addition to a complete downregulation 148 
of pluripotency marker NANOG and inducing a 600-fold upregulation of the 149 
neuronal marker TUJ1, 21 days differentiation induced the expression of 150 
KISS1R and upregulation of TAC3R, ESR2, and GAD65, factors playing 151 
essential roles in regulating GnRH neurons. In addition, differentiation also 152 
induced the expression of markers associated with nasal placode GABA2 and 153 
EYA1 (Sabado et al., 2012) possibly indicating immaturity (or incomplete 154 
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differentiation) of some of the cells. The increase in GFAP could indicate the 155 
presence of Olfactory Ensheathing Cells, glial cells which have been shown to 156 
arise in the nasal placode and to be important in GnRH neurons development 157 
and migration (Geller et al., 2013). 158 
To further investigate the phenotype of our GnRH-ECs we performed a global 159 
mRNA expression analysis comparing ESCs, NPCs and GnRH-ECs. Because 160 
cells subjected to 21 days differentiation continued to express genes present 161 
in very immature GnRH neurons a 35 day differentiation point was included in 162 
the analysis (Suppl Fig 2 and 163 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86990). All neuronal 164 
groups clearly diverged from ESCs (Suppl Fig 1) therefore we concentrated 165 
on just NPCs, 21 days GnRH-ECs, and 35 days GnRH-ECs to look for a 166 
specific gene expression profile for the differentiated GnRH neuronal 167 
phenotype. We performed a hierarchical clustering of differentially expressed 168 
genes using Cluster 3 software. Selecting for probes with variability greater 169 
than 3 SDs between groups we ascribed 1081 differentially expressed entries 170 
(Fig 5 A). As expected, GnRH-ECs clustered together (Fig 5 A). Two groups 171 
of genes were highly expressed in GnRH-ECs as compared with NPCs (Fig 5 172 
A and B, groups a and b). Group a (which contains group b, Suppl Table 1) 173 
was highly expressed mainly in 21 days GnRH-ECs whereas group b was 174 
highly expressed in 35 days GnRH-ECs. The differentially expressed clusters 175 
were analysed using DAVID functional annotation tool (DAVID, 176 
https://david.ncifcrf.gov/). The analysis revealed that 35 days GnRH-ECs 177 
display a slightly more neuroendocrine phenotype than 21 days GnRH-ECs, 178 
with top upregulated pathways related to response to hormonal stimulus, 179 
steroid biosynthesis, and multicellular organism reproduction (Fig 5 D). In 180 
addition, the NF1 family of transcription factors has been implicated in 181 
controlling specificity of GnRH1 expression in GnRH neurons (Givens et al., 182 
2004). Investigation of the tissue expression pattern for these genes carried 183 
out using DAVID associates them with the olfactory bulb (Fig 5 C) from which 184 
GnRH neurons derive and migrate and shares many of their developmental 185 
signals. The olfactory bulb could be one of the closest matches to GnRH 186 
neurons provided by DAVID’s GNF_U133A_QUARTILE database as it does 187 
not contain specific information about GnRH neurons or the embryonic 188 
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olfactory epithelium. Pathway analysis of the same differentially expressed 189 
genes using DAVID functional annotation clustering showed a clear induction 190 
of neuronal differentiation pathways. Induction of genes associated with 191 
response to hormonal signalling was among the 10 highest scoring pathway 192 
clusters affected by terminal differentiation (Fig 5 D, Suppl table 2). 193 
 194 
GnRH-EC display spontaneous and kisspeptin-stimulated calcium transients 195 
To investigate whether ESCs-derived GnRH-ECs produced calcium transients 196 
and expressed functional kisspeptin receptors we loaded 35 days GnRH-ECs 197 
with calcium dye Fluoro4 and measured fluorescence using confocal 198 
microscopy. Approximately 20% of the differentiated cells displayed calcium 199 
transients which were increased in frequency and amplitude by Kisspeptin-10 200 
(Fig 6). This behaviour resembles that of functional GnRH neurons which 201 
produce spontaneous calcium transients that can be stimulated by kisspeptin 202 
both in frequency and amplitude (Han et al., 2005; (Constantin et al., 2009). 203 
Taken together these results show that our protocol efficiently and 204 
consistently generates ESCs and iPSCs-derived GnRH-secreting neurons 205 
with characteristics of true -albeit somehow immature- GnRH neurons. 206 
 207 
Discussion 208 
 209 
The inaccessibility of human GnRH-neurons has been a major impediment to 210 
studying the hypothalamic control of reproduction and its disorders. Here, we 211 
report the efficient generation of GnRH-secreting neurons (GnRH-ECs) from 212 
human ESCs by directed differentiation. Notably, this protocol also works 213 
efficiently and consistently with human iPSCs lines derived from both subjects 214 
with Kallmann syndrome and healthy controls. 215 
Establishing a directed differentiation protocol relies upon understanding the 216 
details of cellular ontogenesis. Our differentiation strategy was based on the 217 
current knowledge about the in vivo development of GnRH neurons. GnRH 218 
neurons arise in the anterior area of the nasal placode (Wierman et al., 2011) 219 
in a niche defined by a gradient of BMP4 and its own target and antagonist 220 
noggin (Forni et al., 2013; Leung et al., 2013). We modified a protocol that 221 
used long term exposure of human ESCs to noggin in a neurogenic medium 222 
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for generating neural progenitor cells (Gerrard et al., 2005). These NPCs 223 
proved to be capable of differentiating into GnRH neurons. FGFs mediate a 224 
vast range of central nervous system developmental processes including 225 
neural induction, proliferation, migration, and cell survival (Mott et al., 2010). 226 
BMP4 and FGF8 are thought to have opposing roles in defining epithelial 227 
versus neurogenic fate in the developing olfactory/vomeronasal system (Forni 228 
et al., 2013). In particular, FGF8 has been implicated in specification of 229 
olfactory and GnRH neurons (Sabado et al., 2012). In addition, it is likely that 230 
some yet-to-be-determined factor(s) could block neural progenitor cells form 231 
developing into GnRH neurons in vivo (Markakis et al., 2004). After exposing 232 
PSCs-derived NPCs to FGF8 for 21 days in basic neuro-epithelial medium, 233 
the cells terminally differentiated into neurons which express and secrete 234 
GnRH. The proportion of terminally differentiated neurons expressing GnRH 235 
varied between experiments (40-90%). It was higher for ESCs-derived NPCs 236 
(60-90%) than for iPSCs-derived NPCs (40-50%), a modest difference which 237 
falls well within the bounds of normal hPSC line variability (Bock et al., 2011). 238 
In vivo, GnRH neurons are phenotypically heterogeneous, complicating the 239 
use of defining markers other than GNRH1 (Han et al., 2005). GnRH-ECs 240 
expressed markers present both in nasal (immature) and hypothalamic GnRH 241 
neurons (Fig 4). In order to obtain a better insight into the phenotype of these 242 
secreting neurons we carried out a global expression analysis. In mammals, 243 
GnRH cells are distributed in a continuum from the olfactory bulbs to the 244 
hypothalamus (Wray, 2002). We used DAVID’s GNF_U133A_QUARTILE 245 
tissue expression database. This database does not contain specific data on 246 
GnRH neurons. To the best of our knowledge there is no available data base 247 
containing specific information on GnRH neurons gene expression patterns. 248 
Our analysis linked GnRH-ECs’ differentially expressed genes to the olfactory 249 
bulb, a rostral brain area proximal to the preoptic area where most GnRH 250 
neuronal bodies reside and intrinsically linked to GnRH neurons development 251 
and migration (Berghard et al., 2012; Hu et al., 2013; Teixeira et al., 2010; 252 
Wray, 2010). In addition to the expected enrichment of pathways associated 253 
to neuronal differentiation, GnRH-ECs presented an enrichment of pathways 254 
related to response to hormones, steroid biosynthesis, and multicellular 255 
organism reproduction. Differentiated cells also showed an increase of 256 
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Nuclear Factor 1 family members. These transcription factors have been 257 
implicated in controlling specificity of GnRH1 expression in GnRH neurons 258 
(Givens et al., 2004). 259 
The production of spontaneous calcium transients whose frequency and 260 
amplitude can be modulated by neuropeptides such as kisspeptin is a 261 
hallmark of GnRH neurons (Constantin et al., 2009; Constantin et al., 2012; 262 
Han et al., 2005). In accordance with this, our differentiated neurons displayed 263 
both spontaneous and kisspeptin-stimulated calcium transients. This is the 264 
first report of in vitro generated, kisspeptin-responsive, GnRH neurons 265 
displaying spontaneous calcium transients. 266 
Taken together, these findings suggest that we have generated cells that 267 
closely resemble GnRH neurons. Our claim that GnRH neurons can be 268 
generated from PSCs is supported by a very recent report by Lund et al. 269 
These researchers produced GnRH-secreting neurons from hPSCs by using 270 
a protocol similar to ours (including BMP4 inhibition followed by FGF8 (Lund 271 
et al., 2016). In our view, our method presents a number of advantages: not 272 
only can NPCs be expanded before differentiation, but our protocol seems to 273 
achieve higher differentiation efficiencies. Crucially cells obtained here are 274 
endowed with a calcium oscillator responsive to Kisspeptin and Glutamate. 275 
These in vitro generated GnRH expressing cells provide a new resource for 276 
studying the neuromolecular mechanisms underlying the development of 277 
GnRH neurons. In addition, these GnRH neurons will enable several new 278 
lines of research including disease modelling, cell transplantation and drug 279 
screening. 280 
 281 
282 
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Materials and Methods 283 
 284 
 285 
Work with human embryonic stem cells was reviewed and approved by the 286 
UK’s Steering Committee For The Stem Cell Bank And For The Use Of Stem 287 
Cell Lines. Use of patient samples was approved by the UK’s National 288 
Research Ethics Service (13/LO/0224). 289 
 290 
Pluripotent stem cells (PSCs) culture 291 
Hues7 Human embryonic stem cells (hESCs) and human induced pluripotent 292 
stem cells (hiPSCs) were maintained on plates coated with Growth Factor 293 
Reduced Matrigel (BD Biosciences) in chemically defined PluriSTEM medium 294 
(Merck Millipore) or mTeSR-1 (Stemcell Technologies) and were passaged by 295 
mechanical dissociation (scrapping) after 5 min incubation in 0.5 mM EDTA 296 
PBS. 297 
 298 
iPSC Reprogramming of human dermal fibroblasts 299 
Human dermal fibroblasts (hDFs) were dissociated using TrypLE (Gibco), 300 
plated on gelatin-coated 6 well plates at a density of 5 × 10^4 cells/well in 301 
10% FBS-DMEM. Twenty four hours after plating hDFs were transduced with 302 
a STEMCCA lentiviral vector (Sommer et al., 2012) using a MOI of 10. Three 303 
days after transduction, hDFs were passaged 1:10 on matrigel coated plates 304 
and incubated in PluriSTEM. Colonies with stem cell-like morphology usually 305 
started to appear at day 14 post-transdution and were picked for expansion 306 
and characterisation of pluripotency from day 21. 307 
 308 
Neuronal differentiation 309 
Neural Progenitor Cells (NPCs) were generated by an adaptation of a 310 
previously published protocol (Gerrard et al., 2005), briefly: PSCs were split 311 
mechanically with 0.5 mM EDTA PBS in 1:4 ratios into culture dishes coated 312 
with matrigel and incubated in Basal Neuro Epithelial (BNE) medium (1:1 mix 313 
of D-MEM/F12 and Neurobasal medium supplemented with N2 and serum-314 
free B27, all from Gibco) supplemented with 100 ng/ml mouse recombinant 315 
noggin (Peprotech). At this stage cells were considered to be at passage 1 316 
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(P1). Cells were allowed to grow until confluence and split at 1:3 ratios using 317 
EDTA PBS and cultured using the same conditions until passage 4 (P4). 318 
Some neuronal rosettes appeared at P3. At P4 plenty of neuronal rosettes 319 
usually took over the culture. If this didn’t happen, cultures were discarded. 320 
From P4 onwards cells were completely dissociated using TrypLE and plated 321 
1:10 on matrigel-coated plates in BNE medium supplemented with 20 ng/ml 322 
human FGFb and 20 ng/ml human EGF (both Peprotech) without noggin. 323 
NPCs were kept in these conditions until P10-11 at which point cells were 324 
discarded. For terminal differentiation, NPCs between P6-P11 were plated at 325 
a density of 5000 cells/cm^2 and incubated either in BNE supplemented with 326 
10 ng/ml FGF8 (Peprotech) or 10 n -[N-(3,5-327 
Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT, Sigma-328 
Aldrich) for 21 days. 329 
 330 
RT-QPCR 331 
Total RNA was extracted using TriReagent (Sigma-Aldrich). For reverse 332 
transcription (RT), RNA (0.5 μg) was reverse transcribed to cDNA using M-333 
MLV Reverse Transcriptase (Promega) and random hexamers (Invitrogen). 334 
Quantitative PCR (QPCR) was performed on diluted cDNA samples with 335 
SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) in an ABI Step One 336 
Plus QPCR system (Applied Biosystems, Carlsbad, CA) using the following 337 
program: 95 °C for 10 minutes, 40 cycles at 95 °C for 15 seconds, 60 °C for 338 
30 seconds, and 72 °C for 30 seconds. Primers used are listed in 339 
Supplementary Table SX and were designed using Primer3 (http://frodo. 340 
wi.mit.edu/primer3). RT-QPCR results were analyzed using the 2–ΔΔCt 341 
method as described by Livak and Schmittgen (2001). The geometric mean of 342 
3 housekeeping genes -Glyceraldehyde-3-phosphate dehydrogenase 343 
(GAPDH), Ribosomal Protein L19 (RPL19), and beta-Actin (bACTIN)- was 344 
used as a calibrator after confirming that the genes were not affected by the 345 
treatment (Livak and Schmittgen, 2001). 346 
 347 
Immunostaining 348 
Cells were fixed for 10 min in 4% formaldehyde (Fisher Scientific) at room 349 
temperature. Fixed cells were incubated over night with primary antibodies in 350 
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0.1% Triton X100, 2% w/v bovine serum albumin (BSA), and 5% normal goat 351 
serum (NGS) in PBS and 1 h at room temperature with secondary antibodies 352 
in 2% w/v BSA PBS. Stained cells were mounted in Vectashield Antifade 353 
Mounting Medium with DAPI (vectorlabs). Antibodies used were: mouse anti-354 
Tra1-60 (Cat. num. MAB4770, R&D Systems), mouse anti-beta III tubulin 355 
(TUJ1) (Cat. num. MAB1195, R&D Systems), rabbit anti-GnRH (Cat. num. 356 
20075, Immunostar), mouse anti-GFAP (Cat. num. G3893, Sigma-Aldrich), 357 
Alexa 488 conjugated goat anti-mouse antibody (Cat. num. A10684, 358 
Invitrogen) and Alexa 568 goat anti-rabbit antibody (Cat. num. A21069, 359 
Invitrogen). 360 
 361 
Flow cytometry 362 
Cells were differentiated as described above. Cells where dissociated by 363 
incubation in 0.1 mg/mL DNase I (D5025 - Sigma-Aldrich) 1X TrypLE 364 
(12605028 - GIBCO) for 30 min at 37oC and gently pipetting up and down 365 
every 5 min. After dissociation cells were washed twice in PBS. Visible 366 
clumps were removed by pipetting them out. Cells were fixed in chilled 4% 367 
formaldehyde PBS for 10 min and washed twice in PBS. Cells were 368 
permeabilized on ice in 100% methanol which had been previously chilled to -369 
20oC. After permeabilization, cells were washed twice in 1% BSA PBS. Cells 370 
were counted using a hemocytometer and 0.5-1 x 106 cells were incubated in 371 
a 1:100 dilution of rabbit anti-GnRH (Cat. num. 20075, Immunostar) in 1% 372 
BSA PBS for 1 h at RT. Cells were washed twice in PBS and incubated in a 373 
1:50 dilution of Alexa 568 goat anti-rabbit antibody (Cat. num. A21069, 374 
Invitrogen) for 1 h. After incubation with secondary antibody cells were 375 
washed three times, resuspended in 1% BSA PBS and analysed in a BD 376 
LSR-Fortessa Cell Analyzer (BD Biosciences) using a blue laser and a YG 377 
610/20A filter. Figures were generated with Flowing Software v2.5.1 378 
(http://www.uskonaskel.fi/flowingsoftware/). 379 
 380 
Immunoblotting  381 
Cell lysates were harvested by the addition of SDS lysis buffer (2% SDS, 30 382 
mM NaCl, 10 mM HEPES, pH 7.4, 20 mM NaF, 1 mM NaPPi, 1 mM PMSF, 383 
and 1X Complete Protease Inhibitor Cocktail [Roche]). Equal amounts of 384 
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protein from lysates were resolved by SDS-PAGE, immunoblotted, and 385 
detected in an Odyssey Imaging System (Li-Cor Biotechnology). Rabbit anti-386 
GnRH antibody was purchased from Immunostar (Cat. Num. 20075). 387 
Secondary IRDye 680RD Goat anti-Rabbit was purchased from Li-Cor 388 
Biotechnology. 389 
 390 
GnRH release 391 
GnRH release to the media was detected using an Enzyme-linked 392 
Immunosorbent Assay (ELISA) Kit (Biomatik) according to manufacturer’s 393 
instructions. Briefly: media was collected, centrifuged 10 min at 1000 xg and 394 
stored at -20oC until measurement. For measurements, standard GnRH curve 395 
was prepared in fresh cell medi396 
samples were used in duplicates. 397 
 398 
Microarray 399 
Total RNA was extracted using TriReagent (Sigma-Aldrich). RNA QC was 400 
performed in a 2100 Bioanalyzer (Agilent Technologies). RNA was labelled 401 
using Ambion Total Prep kit and hybridized on a human Illumina genome wide 402 
gene expression array (HT12v4). Raw data was quartile normalised and 403 
analysed using Illumina's Genome Studio software. P-values were calculated 404 
using the Illumina Custom method followed by a Bonferroni correction to 405 
account for multiple testing. Hierarchical clustering of differentially expressed 406 
genes was performed with Cluster 3 software 407 
(http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) and displayed 408 
using Java TreeView software (https://sourceforge.net/projects/jtreeview/). 409 
Log-transformed row-centred data was used after selecting rows with 410 
standard deviations at least 3 times higher than the array’s SD. The data 411 
discussed in this publication have been deposited in NCBI's Gene Expression 412 
Omnibus (Poliandri et al., 2016) and are accessible through GEO Series 413 
accession number GSE86990 414 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86990) 415 
 416 
Calcium Imaging 417 
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NPCs were differentiated as described above. Cells were grown on glass-418 
bottom petri dishes (Met Tek Corporation, Ashland, MA 01721, USA) for 35 419 
days. 420 
A stock solution of fluo-4 acetoxymethyl ester (Fluo4-AM) (Molecular Probes) 421 
was prepared by adding 50 μl of an 80% DMSO 20% pluronic acid mix to 50 422 
μg of Fluo4-AM. The stock solution was diluted 1:100 in calcium buffer (135 423 
mm NaCl, 2.7 mm KCl, 2 mm CaCl2, 1 mm MgCl2, 0.33 mm NaH2PO4, 5 424 
mm HEPES, 10 mm glucose, pH 7.4) and this dilution was used to load the 425 
cells for 40 min at 37oC in 5% CO2. After loading cells were rinsed in calcium 426 
buffer and incubated for another 40 min at 37oC in 5% CO2 before 427 
measurements. Measurements were performed at 37oC in calcium buffer in a 428 
Zen LSM 510 confocal microscope in line scan mode. A series with a scan 429 
time of 600 msec, 1000 cycles, and an interval of 1 sec between scans was 430 
used. 431 
Images were analysed using ImageJ software with Multi Selection plugin. The 432 
mean background of 3 different regions was subtracted before analysis. At 433 
least 20 cells per field were randomly selected for analysis from the pool of 434 
cells which displayed a calcium increase after a final KCl (100 mM) challenge. 435 
 436 
 437 
 438 
439 
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Figure 1. Generation of Neural Progenitor Cells (NPCs) 440 
 441 
(A) Schematic diagram of how NPCs are generated. Briefly: ESCs are 442 
resuspended in clumps using 5 mM EDTA and a cell scraper. Resuspended 443 
ESCs are then plated at a 1:4 ratio onto matrigel-coated wells with BNE 444 
medium supplemented with 100 ng/ml noggin. At this stage cells are 445 
considered NPCs passage 1 (P1). NPCs are passaged 3 more times using 5 446 
mM EDTA and mechanical dispersion and cultured in BNE medium 447 
supplemented with 100 ng/ml noggin. After P4 cells are completely 448 
dissociated using 1X TripLE and plated onto matirgel-coated wells in BNE 449 
medium supplemented with 20 ng/ml bFGF and 20 ng/ml EGF (P5). During 450 
the differentiation process pluripotency markers are downregulated and 451 
neuronal markers upregulated. (B) QPCR results showing downregulation of 452 
pluripotency markers NANOG and OCT4 (top row) and upregulation of 453 
neuronal markers PAX6 and TUJ1 (bottom row). NPCs can be generated with 454 
similar efficiency using iPSCs derived from healthy subjects (H-iPSCs > H-455 
NPCs) or patients with Kallmann syndrome (P-iPSCs > P-NPCs). (C) 456 
Representative image of P4 H-NPCs and QPCR data showing 457 
downregulation of NANOG and upregulation of PAX6 and TUJ1. (D) 458 
Representative image of P4 P-NPCs and QPCR data showing downregulation 459 
of NANOG and upregulation of PAX6 and TUJ1. Bars represent mean ± SEM. 460 
 461 
 462 
Figure 2. Terminal differentiation of NPCs induces expression and secretion 463 
of GnRH 464 
 465 
Plating NPCs at a low density in BNE medium supplemented with 10 ng/ml 466 
FGF8 for 21 days causes neuronal differentiation and induces the expression 467 
and secretion of GnRH. (A) Terminally differentiated (TD) NPCs. RT-QPCR 468 
and end-point RT-PCR showing an increase of GNRH1 mRNA in Terminally 469 
Differenciated NPCs (TD-NPCs) (A) and (B). ***p<0.001 vs NPCs. (C) 470 
Western blot showing the presence of GnRH peptide in whole-cell lysates of 471 
TD-NPCs. Whole-cell lysates of HEK293 cells and GT1-7 cells were used as 472 
negative and positive controls respectively. NPCs and TD-NPCs secrete 473 
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GnRH. Cells were incubated for 48 h in BNE alone and GnRH accumulation 474 
in the media was measured using an ELISA kit (D). GT1-7 cells were used as 475 
a positive control and all samples were blanked against media alone. *p<0.05 476 
vs NPCs, Student’s t-test, N=3. 477 
 478 
 479 
Figure 3. GnRH expression in different cell lines 480 
 481 
NPCs incubated for 21 days in BNE supplemented with 10 ng/ml FGF8 482 
differentiate into TUJ1-positive neurons and express GnRH. (A) 483 
Immunofluorescence images of GnRH-Expressing Cells (GnRH-ECs) stained 484 
for TUJ1 (green) and GnRH (red). Nuclei were stained with DAPI (blue). 485 
iPSCs-derived NPCs incubated for 21 days in BNE supplemented with 10 486 
ng/ml FGF8 also differentiate into TUJ1-positive neurons and express GnRH. 487 
(B) Immunofluorescence images of ESCs-derived neurons (GnRH-ECs, top 488 
row), healthy iPSCs-derived neurons (H-GnRH-ECs, middle row), and 489 
Kallmann syndrome iPSCs-derived neurons (P-GnRH-ECs, bottom row) 490 
stained for TUJ1 (green) and GnRH (red). Nuclei were stained with DAPI 491 
(blue). (C) Isotype controls: GnRH-ECs were stained without primary 492 
antibodies (top row). P-iPSCs were stained for the pluripotency marker TRA1-493 
60 (green) and GnRH (red) (middle row). GnRH expressing GN11 cells were 494 
stained for TUJ1 (green) and GnRH (red). Nuclei were stained with DAPI 495 
(blue). (D) Flow-cytometry quantification of the number of cells expressing 496 
GnRH. Cells were stained with anti-GnRH antibody and analysed in a BD 497 
LSR Fortressa cell analyser. HEK293(Da) and GN11(Db) cells were used as 498 
negative and positive controls respectively. Up to 90% of ESCs-derived 499 
GnRH-ECs were positive for GnRH (Dc and Dd). Up to 50% of iPSCs-derived 500 
GnRH-ECs were positive for GnRH (De and Df). Few undifferentiated NPCs 501 
were positive for GnRH (Dg). 502 
 503 
 504 
Figure 4. Differentiated neurons express markers present in hypothalamic and 505 
nasal GnRH neurons. 506 
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Differentiation in BNE supplemented with 10 ng/ml FGF8 of ESCs-derived 507 
NPCs for 21 days induced the expression of markers present in GnRH neuron 508 
KISS1R, TAC3R, GAD65, and ESR2. There was also an induction of nasal 509 
epithelium markers GATA2 and EYA1 together with a strong induction of the 510 
neuronal marker TUJ1. There was also an induction of the glial marker GFAP. 511 
The pluripotency marker NANOG was strongly downregulated. Top right 512 
panel: image of 21 day neurons. UND = undetected. *p<0.05 vs control, 513 
***p<0.001 vs control, student’s t-test, N=3. 514 
 515 
 516 
Figure 5. Global expression analysis of GnRH-ECs shows tissue expression 517 
patterns consistent with GnRH neurons’ origin in the nasal epithelium. 518 
Global mRNA expression was measured in NPCs and GnRH-ECs at days 21 519 
and 35 of differentiation using Ilumina HT12v4 microarray. (A) Row-centred 520 
heat map of hierarchical clustering carried out on the differentially expressed 521 
gene probes is shown. Probe sets are coloured according to the average 522 
expression level across all samples, with green denoting a lower expression 523 
level and red denoting a higher expression level. (B) Two groups of genes (a 524 
and b) highly expressed in GnRH-ECs were investigated for tissue expression 525 
pattern and physiological pathways using DAVID Functional Annotation tool. 526 
(C) Top tissue expression patterns enriched in each of the different clusters. 527 
The bars represent significance of enrichment. (D) Top pathways that are 528 
enriched in each of the different clusters. The bars represent significance of 529 
enrichment, % shows the percentage of genes involved in the pathway out of 530 
the total list of genes. 531 
 532 
 533 
Figure 6. GnRH-ECs display spontaneous and kisspeptin-stimulated calcium 534 
transients. 535 
Representative experiments of cells responding to Kisspeptine: Cells were 536 
recorded for 3 min before adding 200 μl of buffer (blue dot) to control for 537 
possible effect on calcium,  after 1 min 200 μl of Kisspeptine (final 538 
concentration 100 nM) were added (red dot), after 3 min glutamate (final 539 
 18 
concentration 1 mM) was added (green dot). Finally KCL (75 mM) was added. 540 
Inset: image of cells loaded with Fluo4. 541 
542 
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